Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

FOTD - basically other than SQ Mabthera there are few short term catalysts that are likely to result in further approvals before 2020. So we have huge expenses for 3 years, which vastly exceed likely revenues - hence my $450m unfunded blackhole. I'm obviously nothing like as optimistic as you about the share price being pumped up by early stage trial results or new Enhanze partners/drugs, where we know it takes 5 years to develop and get approvals.